Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2016, Article ID 1284372, 11 pages
http://dx.doi.org/10.1155/2016/1284372
Research Article

Cross Talk Mechanism among EMT, ROS, and Histone Acetylation in Phorbol Ester-Treated Human Breast Cancer MCF-7 Cells

Laboratory of Clinical Pharmaceutics, Gifu Pharmaceutical University, 1-25-4 Daigaku-nishi, Gifu 501-1196, Japan

Received 11 December 2015; Revised 17 March 2016; Accepted 20 March 2016

Academic Editor: José Luís García-Giménez

Copyright © 2016 Tetsuro Kamiya et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. C. Cave, A. C. Brewer, A. Narayanapanicker et al., “NADPH oxidases in cardiovascular health and disease,” Antioxidants and Redox Signaling, vol. 8, no. 5-6, pp. 691–728, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. I. Vachier, P. Chanez, C. Le Doucen, M. Damon, B. Descomps, and P. Godard, “Enhancement of reactive oxygen species formation in stable and unstable asthmatic patients,” European Respiratory Journal, vol. 7, no. 9, pp. 1585–1592, 1994. View at Publisher · View at Google Scholar · View at Scopus
  3. E. Wright Jr., J. L. Scism-Bacon, and L. C. Glass, “Oxidative stress in type 2 diabetes: the role of fasting and postprandial glycaemia,” International Journal of Clinical Practice, vol. 60, no. 3, pp. 308–314, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. M. J. Serrano, F. G. Ortega, M. J. Alvarez-Cubero et al., “EMT and EGFR in CTCs cytokeratin negative non-metastatic breast cancer,” Oncotarget, vol. 5, no. 17, pp. 7486–7497, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. K. M. Hajra, David Y-S. Chen, and E. R. Fearon, “The SLUG zinc-finger protein represses E-cadherin in breast cancer,” Cancer Research, vol. 62, no. 6, pp. 1613–1618, 2002. View at Google Scholar · View at Scopus
  6. H. P. H. Naber, Y. Drabsch, B. E. Snaar-Jagalska, P. ten Dijke, and T. van Laar, “Snail and Slug, key regulators of TGF-β-induced EMT, are sufficient for the induction of single-cell invasion,” Biochemical and Biophysical Research Communications, vol. 435, no. 1, pp. 58–63, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. D. Olmeda, M. Jordá, H. Peinado, Á. Fabra, and A. Cano, “Snail silencing effectively suppresses tumour growth and invasiveness,” Oncogene, vol. 26, no. 13, pp. 1862–1874, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. H. Peinado, E. Ballestar, M. Esteller, and A. Cano, “Snail mediates E-cadherin repression by the recruitment of the Sin3A/histone deacetylase 1 (HDAC1)/HDAC2 Complex,” Molecular and Cellular Biology, vol. 24, no. 1, pp. 306–319, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. H. Peinado, D. Olmeda, and A. Cano, “Snail, ZEB and bHLH factors in tumour progression: an alliance against the epithelial phenotype?” Nature Reviews Cancer, vol. 7, no. 6, pp. 415–428, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Zheng, Y.-P. Jiang, W. Chen et al., “Snail and slug collaborate on EMT and tumor metastasis through mir-101-mediated EZH2 axis in oral tongue squamous cell carcinoma,” Oncotarget, vol. 6, no. 9, pp. 6797–6810, 2015. View at Publisher · View at Google Scholar · View at Scopus
  11. R. A. Ignotz and J. Massague, “Transforming growth factor-β stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix,” The Journal of Biological Chemistry, vol. 261, no. 9, pp. 4337–4345, 1986. View at Google Scholar · View at Scopus
  12. E. Ioachim, A. Charchanti, E. Briasoulis et al., “Immunohistochemical expression of extracellular matrix components tenascin, fibronectin, collagen type IV and laminin in breast cancer: their prognostic value and role in tumour invasion and progression,” European Journal of Cancer, vol. 38, no. 18, pp. 2362–2370, 2002. View at Publisher · View at Google Scholar · View at Scopus
  13. I. B. Fuchs, W. Lichtenneger, H. Buehler et al., “The prognostic significance of epithelial-mesenchymal transition in breast cancer,” Anticancer Research, vol. 22, no. 6, pp. 3415–3419, 2002. View at Google Scholar · View at Scopus
  14. L. S. Kristensen, H. M. Nielsen, and L. L. Hansen, “Epigenetics and cancer treatment,” European Journal of Pharmacology, vol. 625, no. 1–3, pp. 131–142, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. R. Holliday, “DNA methylation and epigenetic inheritance,” Philosophical Transactions of the Royal Society of London B: Biological Sciences, vol. 326, pp. 329–338, 1990. View at Google Scholar
  16. F. Gaudet, J. G. Hodgson, A. Eden et al., “Induction of tumors in mice by genomic hypomethylation,” Science, vol. 300, no. 5618, pp. 489–492, 2003. View at Publisher · View at Google Scholar · View at Scopus
  17. P. A. Jones and S. B. Baylin, “The epigenomics of cancer,” Cell, vol. 128, no. 4, pp. 683–692, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. Q. H. Zhang, X. H. Dai, Z. M. Dai, and Y. N. Cai, “Genome-scale meta-analysis of DNA methylation during progression of lung adenocarcinoma,” Genetics and Molecular Research, vol. 14, no. 3, pp. 9200–9214, 2015. View at Publisher · View at Google Scholar · View at Scopus
  19. X. Agirre, J. L. Vizmanos, M. J. Calasanz, M. García-Delgado, M. J. Larráyoz, and F. J. Novo, “Methylation of CpG dinucleotides and/or CCWGG motifs at the promoter of TP53 correlates with decreased gene expression in a subset of acute lymphoblastic leukemia patients,” Oncogene, vol. 22, no. 7, pp. 1070–1072, 2003. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Chmelarova, E. Krepinska, J. Spacek, J. Laco, M. Beranek, and V. Palicka, “Methylation in the p53 promoter in epithelial ovarian cancer,” Clinical and Translational Oncology, vol. 15, no. 2, pp. 160–163, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. J. H. Kang, S. J. Kim, D.-Y. Noh et al., “Methylation in the p53 promoter is a supplementary route to breast carcinogenesis: correlation between CpG methylation in the p53 promoter and the mutation of the p53 gene in the progression from ductal carcinoma in situ to invasive ductal carcinoma,” Laboratory Investigation, vol. 81, no. 4, pp. 573–579, 2001. View at Publisher · View at Google Scholar · View at Scopus
  22. B. E. Bernstein, A. Meissner, and E. S. Lander, “The mammalian epigenome,” Cell, vol. 128, no. 4, pp. 669–681, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Esteller, “Epigenetics in cancer,” The New England Journal of Medicine, vol. 358, no. 11, pp. 1148–1159, 2008. View at Publisher · View at Google Scholar
  24. Y. Kondo, L. Shen, A. S. Cheng et al., “Gene silencing in cancer by histone H3 lysine 27 trimethylation independent of promoter DNA methylation,” Nature Genetics, vol. 40, no. 6, pp. 741–750, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. L. Gao, M. A. Cueto, F. Asselbergs, and P. Atadja, “Cloning and functional characterization of HDAC11, a novel member of the human histone deacetylase family,” Journal of Biological Chemistry, vol. 277, no. 28, pp. 25748–25755, 2002. View at Publisher · View at Google Scholar · View at Scopus
  26. V. V. Ogryzko, R. L. Schiltz, V. Russanova, B. H. Howard, and Y. Nakatani, “The transcriptional coactivators p300 and CBP are histone acetyltransferases,” Cell, vol. 87, no. 5, pp. 953–959, 1996. View at Publisher · View at Google Scholar · View at Scopus
  27. S. Y. Roth, J. M. Denu, and C. D. Allis, “Histone acetyltransferases,” Annual Review of Biochemistry, vol. 70, pp. 81–120, 2001. View at Publisher · View at Google Scholar · View at Scopus
  28. S.-O. Lim, J.-M. Gu, M. S. Kim et al., “Epigenetic changes induced by reactive oxygen species in hepatocellular carcinoma: methylation of the e-cadherin promoter,” Gastroenterology, vol. 135, no. 6, pp. 2128.e1–2140.e8, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. T. Kamiya, M. Machiura, J. Makino, H. Hara, I. Hozumi, and T. Adachi, “Epigenetic regulation of extracellular-superoxide dismutase in human monocytes,” Free Radical Biology and Medicine, vol. 61, pp. 197–205, 2013. View at Publisher · View at Google Scholar · View at Scopus
  30. T. Kamiya, J. Makino, H. Hara, N. Inagaki, and T. Adachi, “Extracellular-superoxide dismutase expression during monocytic differentiation of U937 cells,” Journal of Cellular Biochemistry, vol. 112, no. 1, pp. 244–255, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. L. Huang, H.-C. Cheng, R. Isom, C.-S. Chen, R. A. Levine, and B. U. Pauli, “Protein kinase Cε mediates polymeric fibronectin assembly on the surface of blood-borne rat breast cancer cells to promote pulmonary metastasis,” Journal of Biological Chemistry, vol. 283, no. 12, pp. 7616–7627, 2008. View at Publisher · View at Google Scholar · View at Scopus
  32. D. Lu, J. Huang, and A. Basu, “Protein kinase Cε activates protein kinase B/Akt via DNA-PK to protect against tumor necrosis factor-α-induced cell death,” The Journal of Biological Chemistry, vol. 281, no. 32, pp. 22799–22807, 2006. View at Publisher · View at Google Scholar · View at Scopus
  33. D. I. Brown and K. K. Griendling, “Nox proteins in signal transduction,” Free Radical Biology and Medicine, vol. 47, no. 9, pp. 1239–1253, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. B. Rada, C. Hably, A. Meczner et al., “Role of Nox2 in elimination of microorganisms,” Seminars in Immunopathology, vol. 30, no. 3, pp. 237–253, 2008. View at Publisher · View at Google Scholar · View at Scopus
  35. J. Makino, T. Kamiya, H. Hara, and T. Adachi, “TPA induces the expression of EC-SOD in human monocytic THP-1 cells: involvement of PKC, MEK/ERK and NOX-derived ROS,” Free Radical Research, vol. 46, no. 5, pp. 637–644, 2012. View at Publisher · View at Google Scholar · View at Scopus
  36. B. D. Humphreys, S.-L. Lin, A. Kobayashi et al., “Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis,” American Journal of Pathology, vol. 176, no. 1, pp. 85–97, 2010. View at Publisher · View at Google Scholar · View at Scopus
  37. L. Li, D. Zepeda-Orozco, R. Black, and F. Lin, “Autophagy is a component of epithelial cell fate in obstructive uropathy,” American Journal of Pathology, vol. 176, no. 4, pp. 1767–1778, 2010. View at Publisher · View at Google Scholar · View at Scopus
  38. B. L. Allen-Petersen, C. J. Carter, A. M. Ohm, and M. E. Reyland, “Protein kinase Cδ is required for ErbB2-driven mammary gland tumorigenesis and negatively correlates with prognosis in human breast cancer,” Oncogene, vol. 33, no. 10, pp. 1306–1315, 2014. View at Publisher · View at Google Scholar · View at Scopus
  39. S. Huang, N. Ouyang, L. Lin et al., “HGF-induced PKCζ activation increases functional CXCR4 expression in human breast cancer cells,” PLoS ONE, vol. 7, no. 1, Article ID e29124, 2012. View at Publisher · View at Google Scholar · View at Scopus
  40. D. Pal, S. P. Outram, and A. Basu, “Upregulation of PKCη by PKCε and PDK1 involves two distinct mechanisms and promotes breast cancer cell survival,” Biochimica et Biophysica Acta, vol. 1830, no. 8, pp. 4040–4045, 2013. View at Publisher · View at Google Scholar · View at Scopus
  41. M. Tan, P. Li, M. Sun, G. Yin, and D. Yu, “Upregulation and activation of PKCα by ErbB2 through Src promotes breast cancer cell invasion that can be blocked by combined treatment with PKCα and Src inhibitors,” Oncogene, vol. 25, no. 23, pp. 3286–3295, 2006. View at Publisher · View at Google Scholar · View at Scopus
  42. J. Zhang, N. Liu, J. Zhang, S. Liu, Y. Liu, and D. Zheng, “PKCδ protects human breast tumor MCF-7 cells against tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis,” Journal of Cellular Biochemistry, vol. 96, no. 3, pp. 522–532, 2005. View at Publisher · View at Google Scholar · View at Scopus
  43. R. Derynck, R. J. Akhurst, and A. Balmain, “TGF-β signaling in tumor suppression and cancer progression,” Nature Genetics, vol. 29, no. 2, pp. 117–129, 2001. View at Publisher · View at Google Scholar · View at Scopus
  44. A. Ewart-Toland, J. M. Chan, J. Yuan, A. Balmain, and J. Ma, “A gain of function TGFB1 polymorphism may be associated with late stage prostate cancer,” Cancer Epidemiology Biomarkers and Prevention, vol. 13, no. 5, pp. 759–764, 2004. View at Google Scholar · View at Scopus
  45. B. Schmierer and C. S. Hill, “TGFβ-SMAD signal transduction: molecular specificity and functional flexibility,” Nature Reviews Molecular Cell Biology, vol. 8, no. 12, pp. 970–982, 2007. View at Publisher · View at Google Scholar · View at Scopus
  46. S. Kume, T. Uzu, K. Horiike et al., “Calorie restriction enhances cell adaptation to hypoxia through Sirt1-dependent mitochondrial autophagy in mouse aged kidney,” Journal of Clinical Investigation, vol. 120, no. 4, pp. 1043–1055, 2010. View at Publisher · View at Google Scholar · View at Scopus
  47. P. Simic, E. Williams, E. Bell, J. Gong, M. Bonkowski, and L. Guarente, “SIRT1 suppresses the epithelial-to-mesenchymal transition in cancer metastasis and organ fibrosis,” Cell Reports, vol. 3, no. 4, pp. 1175–1186, 2013. View at Publisher · View at Google Scholar · View at Scopus